Washington, DC, March 14, 2014 --(PR.com
)-- Since his entrance into the world of endurance sports nearly three years ago, Dr. Clayton Lawrence has made it a personal goal, and the goal of his non-profit organization LEAP Foundation DC, to bring awareness to and raise support for some of the greatest causes of our time. For the fourth time in those three years, Lawrence will run in the USA Rock ‘N’ Roll marathon supporting the Leukemia and Lymphoma Society.
The Leukemia and Lymphoma Society, or LLS, was established in 1949. It has since become the world’s largest non-profit health organization dedicated to funding research and developing treatments for blood cancer. Blood cancer exists in multiple forms, the major three of which are leukemia, lymphoma, and myeloma. The overarching mission of LLS is to “cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.”
Thousands of people are diagnosed with a form of blood cancer each year. By the end of 2013, LLS predicted that more than 48,000 new cases of leukemia would be reported and that more than 730,000 people were living with or in remission from lymphoma, both Hodgkin and non-Hodgkin lymphoma (NHL). Within and outside of each of these categories are a number of other rare forms of blood cancer. As each person is unique in his or her own blood type, developing treatments and finding cures presents distinct challenges for researchers and scientists.
However, since its inception, the Leukemia and Lymphoma Society has been the driving force behind providing treatments that have drastically increased the survival rate and quality of life among patients with blood cancer. While no cure has been found for any form of cancer, support of LLS has allowed hundreds of thousands of people around the world to live longer, normal, and healthier lives after diagnosis. Each and every donation brings even greater hope towards advancing the Leukemia and Lymphoma Society’s cause, and Dr. Lawrence remains committed to doing his part.
“LLS has done incredible work in bringing unprecedented awareness and resources to leukemia, lymphoma, and myeloma patients. If I can play just a small part in furthering the work that this organization is doing, I would be remiss not to try,” says Lawrence.
For more information on the Leukemia and Lymphoma Society and ways that you can donate to begin making a difference today, please visit http://www.lls.org.